Marshall Wace LLP Buys 37,196 Shares of Premier, Inc. (NASDAQ:PINC)

Marshall Wace LLP grew its position in Premier, Inc. (NASDAQ:PINC - Free Report) by 134.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 64,923 shares of the company's stock after purchasing an additional 37,196 shares during the quarter. Marshall Wace LLP owned approximately 0.07% of Premier worth $1,376,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of PINC. Brandes Investment Partners LP boosted its stake in Premier by 123.1% during the fourth quarter. Brandes Investment Partners LP now owns 842,326 shares of the company's stock worth $17,857,000 after buying an additional 464,710 shares in the last quarter. Franklin Resources Inc. acquired a new stake in Premier during the fourth quarter worth $5,275,000. Assenagon Asset Management S.A. boosted its stake in Premier by 109.8% during the fourth quarter. Assenagon Asset Management S.A. now owns 468,524 shares of the company's stock worth $9,933,000 after buying an additional 245,239 shares in the last quarter. Invesco Ltd. boosted its stake in Premier by 23.6% during the fourth quarter. Invesco Ltd. now owns 719,597 shares of the company's stock worth $15,255,000 after buying an additional 137,306 shares in the last quarter. Finally, ExodusPoint Capital Management LP boosted its stake in Premier by 408.4% during the fourth quarter. ExodusPoint Capital Management LP now owns 169,458 shares of the company's stock worth $3,593,000 after buying an additional 136,129 shares in the last quarter. Institutional investors own 74.41% of the company's stock.

Insider Activity

In other news, General Counsel David L. Klatsky sold 10,000 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $19.53, for a total transaction of $195,300.00. Following the sale, the general counsel now directly owns 90,597 shares of the company's stock, valued at $1,769,359.41. This represents a 9.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.96% of the stock is owned by insiders.

Premier Trading Up 0.3 %

Shares of Premier stock traded up $0.06 during trading on Thursday, reaching $20.41. The company's stock had a trading volume of 715,511 shares, compared to its average volume of 1,261,713. Premier, Inc. has a one year low of $17.23 and a one year high of $23.56. The stock has a 50-day moving average price of $19.00 and a two-hundred day moving average price of $20.45. The stock has a market capitalization of $1.86 billion, a P/E ratio of -204.08 and a beta of 0.51.

Premier Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Sunday, June 15th. Stockholders of record on Sunday, June 1st will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, May 30th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.12%. Premier's payout ratio is -840.00%.

Wall Street Analysts Forecast Growth

PINC has been the topic of a number of recent research reports. Canaccord Genuity Group decreased their price target on shares of Premier from $21.00 to $19.00 and set a "hold" rating on the stock in a research note on Wednesday, February 5th. Piper Sandler cut their price objective on Premier from $21.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Finally, Robert W. Baird cut their price objective on Premier from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Eight research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $20.17.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.